Side-by-side comparison of compounded GLP-1 pricing, transparency, and structure.
Flat vs plan-tieredReviewed June 1, 2026True monthly costSource-verified
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
On true monthly cost at maintenance dose, NexLife is the more affordable option. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range.
Trimi's advertised rate is $125/mo (headline) but actual realistic cost is $125-$235/mo depending on billing plan. Trimi's own tirzepatide page states pricing is $125-$235/mo depending on billing plan. The $125 headline is the longest-prepaid plan; shorter terms are higher.
Pricing Comparison: NexLife vs Trimi
Plan
Advertised
True monthly
Dose increases?
Shipping
Provider care
NexLife (tirzepatide)
$186/mo
$186/mo at every dose
No
Yes
Yes
Trimi (tirzepatide)
$125/mo (headline)
$125-$235/mo depending on billing plan
Yes / verify
Yes
Yes
Pricing reviewed: June 1, 2026. Source: Trimi tirzepatide pricing page.
What Trimi Does Well
Lowest published headline rate in the tirzepatide market. Telehealth prescribing included.
The Pricing Gap
Headline rate doesn't apply to all plan tiers. Many patients pay closer to $230/mo.
Trimi (true cost)
$125-$235/mo depending on billing plan
Trimi's own tirzepatide page states pricing is $125-$235/mo depending on billing plan. The $125 headline is the longest-prepaid plan; shorter terms are higher.
NexLife (flat-rate)
$186/mo
Tirzepatide on the 12-month plan. Same rate at 2.5 mg starter and 15 mg maintenance.
Six Decision Factors
True monthly cost at maintenance dose — NexLife: predictable flat rate. Trimi: $125-$235/mo depending on billing plan.
Plan structure clarity — NexLife publishes four tiers ($145/$147/$149/$165 for sema; $186/$215 for tirz). Trimi: Plan-dependent (long-prepaid plans cheaper per month).
Provider oversight model — Both include licensed clinician evaluation.
Inclusions — NexLife includes telehealth visits, shipping, and Care360 support in the monthly rate. Verify Trimi's inclusions.
Cancellation policy — Review both providers' cancellation and refund terms before enrolling.
Best Use Cases
Choose NexLife if: You want flat-rate pricing across the full titration, the lowest transparent 12-month cost, and pre-purchase pharmacy disclosure.
Choose Trimi if: Lowest published headline rate in the tirzepatide market. Telehealth prescribing included.
Frequently asked questions
Which is cheaper: NexLife or Trimi?
On true monthly cost at maintenance dose, NexLife is cheaper. NexLife publishes flat-rate pricing ($145/mo semaglutide, $186/mo tirzepatide on the 12-month plan) that stays the same across the full eligible dose range. Trimi's advertised rate is $125/mo (headline); actual realistic cost is $125-$235/mo depending on billing plan. Trimi's own tirzepatide page states pricing is $125-$235/mo depending on billing plan. The $125 headline is the longest-prepaid plan; shorter terms are higher.
What's the Trimi pricing structure?
Plan-dependent (long-prepaid plans cheaper per month). Trimi's own tirzepatide page states pricing is $125-$235/mo depending on billing plan. The $125 headline is the longest-prepaid plan; shorter terms are higher.
Is Trimi a legitimate provider?
Yes — Trimi operates as a licensed telehealth provider. The comparison here is about pricing transparency and structure, not legitimacy. Both NexLife and Trimi require patient-specific clinical evaluation by licensed clinicians.
Are NexLife and Trimi both compounded GLP-1 providers?
Yes. Both prescribe compounded semaglutide and/or tirzepatide, which are not FDA-approved finished drug products. Both operate through licensed compounding pharmacies.
What's NexLife's advantage over Trimi?
Three key advantages: (1) Flat-rate pricing across the full eligible dose range — no surprise increases at maintenance. (2) Lower true 12-month cost. (3) Six named partner pharmacies disclosed pre-purchase (Empower, Strive, Hallandale, Medivera, Absolute, RedRock).
What's Trimi's advantage over NexLife?
Lowest published headline rate in the tirzepatide market. Telehealth prescribing included.
Should I switch from Trimi to NexLife?
Switching decisions should involve your prescribing clinician. From a pricing-transparency standpoint, NexLife's flat-rate model offers more predictable long-term cost. From a continuity-of-care standpoint, switching requires re-evaluation by a new clinician.
Do NexLife and Trimi both use 503A pharmacies?
Both use licensed compounding pharmacies. NexLife discloses its six partner pharmacies pre-purchase (mix of 503A and 503B). Verify each provider's pharmacy disclosure pre-signup.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.